A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
Published: September 11, 2017 at 02:00AM
from NYT Health https://ift.tt/2vPB8zT
A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
Published: September 11, 2017 at 02:00AM
from NYT Health https://ift.tt/2vPB8zT